arthyperАртериальная гипертензия"Arterial’naya Gipertenziya" ("Arterial Hypertension")1607-419X2411-8524Antihypertensive League10.18705/1607-419X-2007-13-1-76-80arthyper-1110Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИORIGINAL ARTICLESИзучение эффективности карведилола в монотерапии и в комбинации с амлодипином у больных с мягкой и умеренной артериальной гипертонией в сочетании с гиперлипидемией (многоцентровое открытое титрационное исследование)Efficacy of carvedolol alone and in combination with amlodipine in a multicenter uncontrolled titration study in patients with hypertension and hypercholesterolemiaСвиряевЮ. В.SviryaevYu. V.noemail@neicon.ruЗвартауН. Э.ZvartauN. E.noemail@neicon.ruРотарьО. П.RotariO. P.noemail@neicon.ruДорофейковВ. В.DorofeikovV. V.noemail@neicon.ruКонрадиА. О.KonradyA. O.noemail@neicon.ruФедеральный Центр сердца, крови и эндокринологии им. В.А.Алмазова РосздраваРоссияAlmazov Federal Center of Heart, Blood an EndocrinologyRussian Federation2007280220071317680Copyright © Свиряев Ю.В., Звартау Н.Э., Ротарь О.П., Дорофейков В.В., Конради А.О., 20072007Свиряев Ю.В., Звартау Н.Э., Ротарь О.П., Дорофейков В.В., Конради А.О.Sviryaev Y.V., Zvartau N.E., Rotari O.P., Dorofeikov V.V., Konrady A.O.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://htn.almazovcentre.ru/jour/article/view/1110

В рамках неконтролируемого открытого титрационного исследования проводилось изучение эффективности карведилола (Таллитон, ЭГИС АО) и его комбинации с амлодипином (Кардилопин, Эгис АО) у больных мягкой и умеренной АГ в сочетании с дислипидемией. Результаты исследования показали высокую эффективность как монотерапии карведилолом, так и комбинированной терапии, а также возможности позитивных эффектов в плане коррекции дислипидемии.

In a multicenter uncontrolled titration study efficacy of carvedilol alone and in combination with amlodipine was studies in patients with hypertension and hypercholesterolemia. The study showed high efficacy of carvedilol as a monotherapy and combined with amlodipine in correction of hypertension and positive changes in lipid profile.

карведилоламлодипинартериальная гипертензиядислипидемияhypertensionamlodipinecarvediloldyslipidemiaReferencesDargie H.J. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial// Lancet 2001; 357:1385-1390.Dargie H.J. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial// Lancet 2001; 357:1385-1390.Krum H. et al. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. JAMA. 2003;289:712-8.Krum H. et al. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. JAMA. 2003;289:712-8.Packer M., Colucci W.S., Sackner-Bernstein J.O. et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise// Circulation. 1996;94:2793-9.Packer M., Colucci W.S., Sackner-Bernstein J.O. et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise// Circulation. 1996;94:2793-9.Stienen U. et al. The Once-Daily Dose Regimen of Carvedilol: a Meta-analysis Approach//Journal of Cardiovascular Pharmacology 1992,19 (Suppl.l):128-133.5.Stienen U. et al. The Once-Daily Dose Regimen of Carvedilol: a Meta-analysis Approach//Journal of Cardiovascular Pharmacology 1992,19 (Suppl.l):128-133.5.Giugliano D.,Acampora R., Marfella R. et al. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial// Ann Intern Med. 1997;126:955-959.6.Giugliano D.,Acampora R., Marfella R. et al. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial// Ann Intern Med. 1997;126:955-959.6.Sica D. Current concepts of pharmacotherapy in hypertension. Carvedilol: new considerations for its use in the diabetic patient with hypertension// J Clin Hypertens (Greenwich). 2005;7:59-64.Sica D. Current concepts of pharmacotherapy in hypertension. Carvedilol: new considerations for its use in the diabetic patient with hypertension// J Clin Hypertens (Greenwich). 2005;7:59-64.Bakris G.L., Fonseca V., Katholi R.R. et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA. 2004;292:2227-2236.Bakris G.L., Fonseca V., Katholi R.R. et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA. 2004;292:2227-2236.Ma X.L., Lopez B.L., Liu G.L. et al. Hypercholesterolemia impairs a detoxification mechanism against peroxynitrite and renders the vascular tissue more susceptible to oxidative injury// Circ Res. 1997;80:894-901.Ma X.L., Lopez B.L., Liu G.L. et al. Hypercholesterolemia impairs a detoxification mechanism against peroxynitrite and renders the vascular tissue more susceptible to oxidative injury// Circ Res. 1997;80:894-901.Hauf-Zachariou U., Widmann L., Zulsdorf B. A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.Hauf-Zachariou U., Widmann L., Zulsdorf B. A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.Uzunlulu M., Oguz A., Yorulmaz E. The effect of carvedilol on metabolic parameters in patients with metabolic syndrome. Int Heart J. 2006;47:421-430.Uzunlulu M., Oguz A., Yorulmaz E. The effect of carvedilol on metabolic parameters in patients with metabolic syndrome. Int Heart J. 2006;47:421-430.

The authors declare that there are no conflicts of interest present.